Jennifer Oki
Impact in
- Aging top 5%
Papers in
-
- SARS-CoV-2 and COVID-19 Research 1
- COVID-19 Clinical Research Studies 1
- Co-authors
- Maxim N. ShokhirevPeter LotfySilvana KonermannNicholas J. BrideauPatrick D. HsuKevin HoldenDavid S. ConantJoyce Yang
- Partner nations
- United States
In The Last Decade
Jennifer Oki
5 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Business and International Management 81
- Aging 56
- Molecular Biology 1.2k
- Infectious Diseases 230
- Cancer Research 104
Countries citing papers authored by Jennifer Oki
This map shows the geographic impact of Jennifer Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Oki more than expected).
Fields of papers citing papers by Jennifer Oki
This network shows the impact of papers produced by Jennifer Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Oki. The network helps show where Jennifer Oki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jennifer Oki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | Inference of CRISPR Edits from Sanger Trace Data Hit paper breakdown → | 2022 | 353 |
| 3 | 2021 | 77 | |
| 4 | 2020 | 260 | |
| 5 | Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors Hit paper breakdown → | 2018 | 826 |
About Jennifer Oki
Jennifer Oki is a scholar working on Infectious Diseases, Animal Science and Zoology, Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology, having authored 5 papers that have together received 1.5k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Virus-based gene therapy research (1 paper), Viral Infections and Immunology Research (1 paper), COVID-19 Clinical Research Studies (1 paper), CAR-T cell therapy research (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Business and International Management (81 citations), Aging (56 citations), Molecular Biology (1.2k citations), Infectious Diseases (230 citations) and Cancer Research (104 citations). Jennifer Oki has collaborated with scholars based in United States. Frequent co-authors include Maxim N. Shokhirev, Peter Lotfy, Silvana Konermann, Nicholas J. Brideau, Patrick D. Hsu, Kevin Holden, David S. Conant, Joyce Yang, Nicholas A. Rossi and Reed Kelso. Their work appears in journals such as Cell, The CRISPR Journal and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.